Medscape8d
Current, New and Novel Therapy for Castration-Resistant Prostate Cancer
RECIST criteria are inadequate for measuring ... For this reason, The Prostate Cancer Clinical Trials Working Group has defined radiological progression as the development of two or more lesions ...
Medscape7d
Randomized Phase II Trial of Nintedanib, Afatinib and Sequential Combination in Castration-Resistant Prostate Cancer
The RECIST-evaluable patients included patients ... have been implicated as important in castration-resistant prostate cancer. Synergistic anti-tumor activity has been reported with the sequential ...
Prostate cancer cases spike in this US state as doctors share likely reason
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...
LAist on MSN4d
Aggressive prostate cancer is surging in California. What you need to know
Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...
pharmaphorum4d
Endocyte bounces back with late-stage prostate cancer deal
The deal sees Endocyte acquire an exclusive worldwide licence for ABX’s phase 3-ready prostate cancer candidate 177Lu ... in 40% to 60% of patients, and a RECIST response rate in soft tissue ...